Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Samonis

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
Journal of Clinical Medicine|August 29, 2024
Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?Aikaterini I Liakou, Andreas G Tsantes, Eleni Routsi, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin BFritz Offner, Vladimir Krcmery, Marc Boogaerts, et al.
Clinical Lung Cancer|May 10, 2011
Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II studyAthanasios G Pallis, Kostas Syrigos, Athanasios Kotsakis, et al.
Journal of Clinical Microbiology|December 17, 2025
Biofilms in clinical infection: pathophysiology, diagnosis, and the evolving therapeutic landscapeAglaia Domouchtsidou, Petros Ioannou, Alexandra Lianou, et al.
Blood Transfusion = Trasfusione Del Sangue|August 12, 2024
Assessment of metabolic and hemostatic profile of apheresis platelet concentrates: does the storage medium play a role?Eleni Petrou, Stavros Tsalas, Andreas G Tsantes, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 10, 2026
Dalbavancin for infective endocarditis: A systematic review of effectiveness, safety, and dosingAnastasios E Chaldoupis, Vasilios Petrakis, Petros Ioannou, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 10, 2026
Reply to the comment on: "Dalbavancin for infective endocarditis: a systematic review of effectiveness, safety, and dosing"Anastasios E Chaldoupis, Vasilios Petrakis, Petros Ioannou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trialVassilis Georgoulias, Alexandros Ardavanis, Xanthi Tsiafaki, et al.
Cancers|June 19, 2024
Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current GuidelinesAndreas G Tsantes, Eleni Petrou, Konstantina A Tsante, et al.
Microorganisms|March 27, 2025
Risk Factors for Flares and New Lesions of Hidradenitis Suppurativa Following COVID-19 Disease: A Retrospective Cohort Study of 310 Patients in GreeceAikaterini I Liakou, Andreas G Tsantes, Evangelia-Konstantina Bompou, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
Journal of Clinical Medicine|August 29, 2024
Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?Aikaterini I Liakou, Andreas G Tsantes, Eleni Routsi, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin BFritz Offner, Vladimir Krcmery, Marc Boogaerts, et al.
Clinical Lung Cancer|May 10, 2011
Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II studyAthanasios G Pallis, Kostas Syrigos, Athanasios Kotsakis, et al.
Journal of Clinical Microbiology|December 17, 2025
Biofilms in clinical infection: pathophysiology, diagnosis, and the evolving therapeutic landscapeAglaia Domouchtsidou, Petros Ioannou, Alexandra Lianou, et al.
Blood Transfusion = Trasfusione Del Sangue|August 12, 2024
Assessment of metabolic and hemostatic profile of apheresis platelet concentrates: does the storage medium play a role?Eleni Petrou, Stavros Tsalas, Andreas G Tsantes, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 10, 2026
Dalbavancin for infective endocarditis: A systematic review of effectiveness, safety, and dosingAnastasios E Chaldoupis, Vasilios Petrakis, Petros Ioannou, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 10, 2026
Reply to the comment on: "Dalbavancin for infective endocarditis: a systematic review of effectiveness, safety, and dosing"Anastasios E Chaldoupis, Vasilios Petrakis, Petros Ioannou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trialVassilis Georgoulias, Alexandros Ardavanis, Xanthi Tsiafaki, et al.
Cancers|June 19, 2024
Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current GuidelinesAndreas G Tsantes, Eleni Petrou, Konstantina A Tsante, et al.
Microorganisms|March 27, 2025
Risk Factors for Flares and New Lesions of Hidradenitis Suppurativa Following COVID-19 Disease: A Retrospective Cohort Study of 310 Patients in GreeceAikaterini I Liakou, Andreas G Tsantes, Evangelia-Konstantina Bompou, et al.
Pageof 24